chr4-3160329-C-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001388492.1(HTT):c.3801C>T(p.Leu1267Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.294 in 1,552,978 control chromosomes in the GnomAD database, including 71,274 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.24   (  5646   hom.,  cov: 32) 
 Exomes 𝑓:  0.30   (  65628   hom.  ) 
Consequence
 HTT
NM_001388492.1 synonymous
NM_001388492.1 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  1.59  
Publications
23 publications found 
Genes affected
 HTT  (HGNC:4851):  (huntingtin) Huntingtin is a disease gene linked to Huntington's disease, a neurodegenerative disorder characterized by loss of striatal neurons. This is thought to be caused by an expanded, unstable trinucleotide repeat in the huntingtin gene, which translates as a polyglutamine repeat in the protein product. A fairly broad range of trinucleotide repeats (9-35) has been identified in normal controls, and repeat numbers in excess of 40 have been described as pathological. The huntingtin locus is large, spanning 180 kb and consisting of 67 exons. The huntingtin gene is widely expressed and is required for normal development. It is expressed as 2 alternatively polyadenylated forms displaying different relative abundance in various fetal and adult tissues. The larger transcript is approximately 13.7 kb and is expressed predominantly in adult and fetal brain whereas the smaller transcript of approximately 10.3 kb is more widely expressed. The genetic defect leading to Huntington's disease may not necessarily eliminate transcription, but may confer a new property on the mRNA or alter the function of the protein. One candidate is the huntingtin-associated protein-1, highly expressed in brain, which has increased affinity for huntingtin protein with expanded polyglutamine repeats. This gene contains an upstream open reading frame in the 5' UTR that inhibits expression of the huntingtin gene product through translational repression. [provided by RefSeq, Jul 2016] 
HTT Gene-Disease associations (from GenCC):
- Huntington diseaseInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- Lopes-Maciel-Rodan syndromeInheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- juvenile Huntington diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56). 
BP6
Variant 4-3160329-C-T is Benign according to our data. Variant chr4-3160329-C-T is described in ClinVar as Benign. ClinVar VariationId is 1599466.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BP7
Synonymous conserved (PhyloP=1.6 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.367  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.240  AC: 36523AN: 152040Hom.:  5641  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
36523
AN: 
152040
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.287  AC: 45697AN: 159328 AF XY:  0.281   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
45697
AN: 
159328
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.300  AC: 420467AN: 1400820Hom.:  65628  Cov.: 32 AF XY:  0.297  AC XY: 205228AN XY: 691090 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
420467
AN: 
1400820
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
205228
AN XY: 
691090
show subpopulations 
African (AFR) 
 AF: 
AC: 
1498
AN: 
31992
American (AMR) 
 AF: 
AC: 
9939
AN: 
35856
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
7738
AN: 
25164
East Asian (EAS) 
 AF: 
AC: 
13598
AN: 
36452
South Asian (SAS) 
 AF: 
AC: 
14851
AN: 
79384
European-Finnish (FIN) 
 AF: 
AC: 
21194
AN: 
49482
Middle Eastern (MID) 
 AF: 
AC: 
708
AN: 
5700
European-Non Finnish (NFE) 
 AF: 
AC: 
334597
AN: 
1078738
Other (OTH) 
 AF: 
AC: 
16344
AN: 
58052
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.457 
Heterozygous variant carriers
 0 
 14446 
 28893 
 43339 
 57786 
 72232 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 11102 
 22204 
 33306 
 44408 
 55510 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.240  AC: 36530AN: 152158Hom.:  5646  Cov.: 32 AF XY:  0.243  AC XY: 18051AN XY: 74374 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
36530
AN: 
152158
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
18051
AN XY: 
74374
show subpopulations 
African (AFR) 
 AF: 
AC: 
2460
AN: 
41554
American (AMR) 
 AF: 
AC: 
3846
AN: 
15292
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1086
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
1965
AN: 
5162
South Asian (SAS) 
 AF: 
AC: 
917
AN: 
4830
European-Finnish (FIN) 
 AF: 
AC: 
4661
AN: 
10574
Middle Eastern (MID) 
 AF: 
AC: 
44
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
20861
AN: 
67966
Other (OTH) 
 AF: 
AC: 
467
AN: 
2108
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.499 
Heterozygous variant carriers
 0 
 1310 
 2621 
 3931 
 5242 
 6552 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 386 
 772 
 1158 
 1544 
 1930 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1057
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.